K

Kyungdong Pharm
KOSDAQ:011040

Watchlist Manager
Kyungdong Pharm
KOSDAQ:011040
Watchlist
Price: 5 790 KRW 0.87%
Market Cap: 156.3B KRW

Operating Margin
Kyungdong Pharm

2.5%
Current
-3%
Average
6%
Industry

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
2.5%
=
Operating Profit
4.8B
/
Revenue
194.4B

Operating Margin Across Competitors

Country Company Market Cap Operating
Margin
KR
Kyungdong Pharm
KOSDAQ:011040
154.6B KRW
2%
US
Eli Lilly and Co
NYSE:LLY
1T USD
44%
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP
3%
US
Johnson & Johnson
NYSE:JNJ
498.9B USD
27%
CH
Roche Holding AG
SIX:ROG
261.4B CHF
34%
UK
AstraZeneca PLC
LSE:AZN
210.8B GBP
24%
CH
Novartis AG
SIX:NOVN
210.3B CHF
33%
US
Merck & Co Inc
NYSE:MRK
264.8B USD
38%
DK
Novo Nordisk A/S
CSE:NOVO B
1.5T DKK
42%
IE
Endo International PLC
LSE:0Y5F
213.9B USD
11%
US
Pfizer Inc
NYSE:PFE
143.2B USD
29%
No Stocks Found

Kyungdong Pharm
Glance View

Market Cap
156B KRW
Industry
Pharmaceuticals

KYUNG DONG PHARMACEUTICAL Co., Ltd. engages in the manufacture and sale of medicines for liver therapy, gastrointestinal, antimigrain, osteoporosis, cardiovascular, antiviral, antiobesity, muscle relaxant, neuropathic, antibacterial, antidiabetic, central nervous system, antifungal, urology, antispasmodic, pain and inflammation, antihistamine, vitamin, repiratory, antiinflammatory enzyme, respiratory and others. The company is headquartered in Hwaseong, Gyeonggi-Do. is a Korea-based company engaged in the manufacture and marketing of pharmaceutical products. The Company’s products include liver therapies, gastrointestinal drugs, antimigraine drugs, antiviral, anti-obesity medications, antibacterial drugs, antidiabetic drugs, antifungal, allergy medications, antispasmodics, antihistamines, vitamins, as well as drugs for osteoporosis, cardiovascular, muscle relaxant, neuropathic and other diseases. The company also provides various over-the-counter (OTC) drugs, such as anti-inflammatory medicines, antiviral drugs, antihistamine drugs, gastrointestinal drugs and others. In addition, the Company engages in the leasing of real estate, and distribution of snowboards and health functional food.

Intrinsic Value
5 697.54 KRW
Overvaluation 2%
Intrinsic Value
Price
K
What is Operating Margin?

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
2.5%
=
Operating Profit
4.8B
/
Revenue
194.4B
What is the Operating Margin of Kyungdong Pharm?

Based on Kyungdong Pharm's most recent financial statements, the company has Operating Margin of 2.5%.

Back to Top